Practice owners
Specialties
Choose a specialtyTransition questions tailored to the way your practice operates.
PsychiatryContinuity, prescribing, telehealthGastroenterologyProcedures, recall, ASC interestsOphthalmologySurgery, optical, ASC interestsDermatologyMedical, Mohs, cosmetic mixUrologyProcedures, call, ancillariesOrthopedic SurgerySurgical mix, PT, imaging
Other specialtyBegin with a discovery conversationAll practice-owner services
BuyersMethodologyResourcesAbout usRequest Workup
Menu
Practice ownersBuyersResourcesMethodologyAbout usFAQ

Specialties

PsychiatryContinuity, prescribing, telehealthGastroenterologyProcedures, recall, ASC interestsOphthalmologySurgery, optical, ASC interestsDermatologyMedical, Mohs, cosmetic mixUrologyProcedures, call, ancillariesOrthopedic SurgerySurgical mix, PT, imagingOther specialtyDiscovery conversation
Request Workup

Fictional sample | Dermatology

A dermatology Transition Workup, shown in practical terms.

This fictional example demonstrates how submitted business facts are distilled into a path, an indicative planning range or evidence-required status, risks, and priorities.

Request your Workup

Doc2Doc Transition Workup | Fictional practice | Founder-reviewed format

Main Line Dermatology Group

Dermatology | No PHI included | Core operating-practice economics only

Executive summary

This practice has documented demand and enough operating clarity to justify preparation for a controlled transition process. The owner should assemble source financials and specialty-specific evidence before initiating introductions. The indicative planning range below applies only to core operating-practice economics.

Recommended pathPrepare for sale
Indicative range$428,000 - $731,000
Expected arc9-18 months

Submitted snapshot

InputFictional estimate
Business inputTwo-clinician partnership
Business input$1.32M collections
Business input$390,000 replacement compensation estimate
Specialty focusmedical, Mohs, and cosmetic mix, pathology, devices, product inventory, and surveillance continuity
Separate value considerationCosmetic products, device value, and pathology-related economics are treated separately from the core medical practice range.

Value drivers

  • Stable medical dermatology demand
  • Surveillance and recall workflows
  • Staff and procedural operating protocols

Risks to resolve

  • Owner-specific cosmetic following
  • Mohs or pathology relationships
  • Lasers, injectables, product inventory, and device leases

Evidence requests

  • Medical, Mohs, and cosmetic revenue split
  • Surveillance and pathology workflows
  • Device and inventory schedules

30 / 90 / 365-day priorities

30 daysNormalize financials, identify separate assets, and confirm continuity and records responsibilities.
90 daysResolve evidence gaps, test credentialing and transfer assumptions, and select an advisor-supported path.
365 daysExecute the chosen transition with controlled introductions and documented continuity safeguards.

This is a fictional planning example, not a certified valuation opinion or a promise of transaction outcome. Qualified professional advisors must evaluate source documents and transaction terms.